Global Pharmaceutical CRDMO Service Supply, Demand and Key Producers, 2023-2029

Global Pharmaceutical CRDMO Service Supply, Demand and Key Producers, 2023-2029

The global Pharmaceutical CRDMO Service market size is expected to reach $ 132.8 million by 2029, rising at a market growth of 6.5% CAGR during the forecast period (2023-2029).

This report studies the global Pharmaceutical CRDMO Service demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Pharmaceutical CRDMO Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pharmaceutical CRDMO Service that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Pharmaceutical CRDMO Service total market, 2018-2029, (USD Million)

Global Pharmaceutical CRDMO Service total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Pharmaceutical CRDMO Service total market, key domestic companies and share, (USD Million)

Global Pharmaceutical CRDMO Service revenue by player and market share 2018-2023, (USD Million)

Global Pharmaceutical CRDMO Service total market by Type, CAGR, 2018-2029, (USD Million)

Global Pharmaceutical CRDMO Service total market by Application, CAGR, 2018-2029, (USD Million)

This reports profiles major players in the global Pharmaceutical CRDMO Service market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BioDuro-Sundia, Sai Life Sciences, Icosagen, WuXi Biologics, WuXi AppTec, Esco Aster, Jubilant Biosys, Syngene International and Chemveda, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pharmaceutical CRDMO Service market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Pharmaceutical CRDMO Service Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Pharmaceutical CRDMO Service Market, Segmentation by Type
Small Molecule CRDMO Service
Middle Molecule CRDMO Service
Large Molecule CRDMO Service

Global Pharmaceutical CRDMO Service Market, Segmentation by Application
Oncology
Infectious Disease
Neurology
Immunology
Hematology
Vaccine
Others

Companies Profiled:
BioDuro-Sundia
Sai Life Sciences
Icosagen
WuXi Biologics
WuXi AppTec
Esco Aster
Jubilant Biosys
Syngene International
Chemveda
Ardena Holding
Eurofins
Jiangsu HUAYI Technology Co., Ltd.

Key Questions Answered

1. How big is the global Pharmaceutical CRDMO Service market?

2. What is the demand of the global Pharmaceutical CRDMO Service market?

3. What is the year over year growth of the global Pharmaceutical CRDMO Service market?

4. What is the total value of the global Pharmaceutical CRDMO Service market?

5. Who are the major players in the global Pharmaceutical CRDMO Service market?

6. What are the growth factors driving the market demand?